QGEN

#956
Qiagen N.V. Common Shares
43.4 6 USD
-0.01%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
43.34
43.57
Jahresspanne
32.53
57.82
Tagesänderung
-0.89%
Monatliche Änderung
+2.55%
6 month change
-5.17%
Jahresänderung
-8.37%
Vorheriger Schlusskurs
43.8 5
Open
43.5 3
Tief
43.3 4
Hoch
43.5 7
Volumen
1 020
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, Q2 FY2026
QIAGEN N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
QIAGEN N.V. current report, Q2 FY2026
6-K
Current report, Q2 FY2026
QIAGEN N.V. current report, Q2 FY2026
6-K
Current report, Q1 FY2026
QIAGEN N.V. current report, Q1 FY2026
6-K
Current report, Q1 FY2026
QIAGEN N.V. current report, Q1 FY2026
6-K
Current report, Q1 FY2026
QIAGEN N.V. current report, Q1 FY2026
6-K

2025

Annual report, Q4 FY2025
QIAGEN N.V. annual report, Q4 FY2025
20-F
Current report, Q4 FY2025
QIAGEN N.V. current report, Q4 FY2025
6-K
Current report, Q4 FY2025
QIAGEN N.V. current report, Q4 FY2025
6-K
Current report, Q3 FY2025
QIAGEN N.V. current report, Q3 FY2025
6-K

QIAGEN N.V. current report, Q4 FY2024

Full document

QIAGEN N.V. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K filing by QIAGEN N.V. (NYSE: QGEN; Frankfurt: QIA) reports unaudited financial results for the fourth quarter and full year ended December 31, 2024. The filing, dated February 6, 2025, incorporates by reference a press release issued on February 5, 2025, which contains the detailed financial data.

Key Financial Metrics

The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the incorporated press release (Exhibit 99.1) referenced in the document. The company reports both GAAP and non-GAAP adjusted results, with the latter excluding costs related to business integration, restructuring, impairments, and amortization of acquired intangible assets.

Material Changes and Methodology

Management utilizes non-GAAP measures and constant currency analysis to evaluate performance, noting that exchange rate fluctuations significantly impact reported growth rates. The filing does not detail specific period-over-period changes in the text provided, as the quantitative comparisons are located in the attached press release.

Guidance, Outlook, and Risks

The company states it does not reconcile forward-looking non-GAAP financial measures to GAAP measures due to the high variability and difficulty in forecasting future decisions and actions. The filing highlights that excluded items (such as restructuring and impairment costs) will have a significant impact on GAAP results. No specific guidance or risk factors are detailed in the text of this Form 6-K summary.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated February 5, 2025) for specific revenue, net income, and cash flow figures.
  • Examine the reconciliation tables in the press release to understand the difference between GAAP and adjusted non-GAAP results.
  • Verify the impact of currency fluctuations on reported growth by comparing constant currency figures to reported figures.
  • Assess the magnitude of excluded items (restructuring, impairments, amortization) to gauge their effect on core operational profitability.

Nachrichten